Loading...
Derniers dépôts
-
Sudir Sumarheni, Saw See Hong, Véronique Josserand, Jean-Luc Coll, Pierre Boulanger, et al.. Human full-length coagulation factor X and a GLA domain-derived 40-mer polypeptide bind to different regions of the adenovirus serotype 5 hexon capsomer.. Human Gene Therapy, 2014, 25 (4), pp.339-49. ⟨10.1089/hum.2013.222⟩. ⟨hal-01100391⟩
-
Emilie Vassal-Stermann, Manon Mottet, Corinne N Ducournau, Frédéric Iseni, Charles Vragniau, et al.. Mapping of Adenovirus of serotype 3 fibre interaction to desmoglein 2 revealed a novel ‘non-classical’ mechanism of viral receptor engagement. Scientific Reports, 2018, 8 (1), pp.8381. ⟨10.1038/s41598-018-26871-x⟩. ⟨hal-01810699⟩
-
Maximilian Richter, Roma Yumul, Hongjie Wang, Kamola Saydaminova, Martin Ho, et al.. Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin.. Molecular Therapy - Methods and Clinical Development, 2015, 2, pp.15005. ⟨10.1038/mtm.2015.5⟩. ⟨hal-01162665⟩
-
Elda Bauda, Benoit Gallet, Jana Moravcova, Gregory Effantin, Helena Chan, et al.. Ultrastructure of macromolecular assemblies contributing to bacterial spore resistance revealed by in situ cryo-electron tomography. Nature Communications, 2024, 15 (1), pp.1376. ⟨10.1038/s41467-024-45770-6⟩. ⟨hal-04747048⟩
-
Uriel López-Sánchez, Lachlan Jake Munro, Lucy Kate Ladefoged, Anders Juel Pedersen, Christian Colding Brun, et al.. Structural determinants for activity of the antidepressant vortioxetine at human and rodent 5-HT3 receptors. Nature Structural and Molecular Biology, 2024, 31 (8), pp.1232-1242. ⟨10.1038/s41594-024-01282-x⟩. ⟨hal-04735636⟩
-
Andrew J Gale, Vikas Bhat, Jean-Luc Pellequer, John H Griffin, Laurent O Mosnier, et al.. Safety, Stability and Pharmacokinetic Properties of (super)Factor Va, a Novel Engineered Coagulation Factor V for Treatment of Severe Bleeding.. Pharmaceutical Research, 2016, 33 (6), pp.1517-26. ⟨10.1007/s11095-016-1895-3⟩. ⟨hal-01341163⟩